AVUV vs XLV
Avantis US Small Cap Value ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.25% for AVUV.
- • XLV pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | AVUV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.25% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.29% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $26.16B | $37.88B |
YTD return | 18.36% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.10 | 0.58 |
P/E ratio | 13.44 | 26.68 |
Last price | $119.18 | $144.72 |
Inception | — | — |
Issuer | Avantis | State Street |
AVUV top holdings
| VSAT | Viasat Inc | 1.09% |
| SM | SM Energy Co | 0.94% |
| MATX | Matson Inc | 0.92% |
| AVT | Avnet Inc | 0.88% |
| FIVE | Five Below Inc | 0.81% |
| GATX | GATX Corp | 0.80% |
| LEA | Lear Corp | 0.79% |
| SNEX | StoneX Group Inc | 0.76% |
| AROC | Archrock Inc | 0.75% |
| PLXS | Plexus Corp | 0.75% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About AVUV
AVUV (Avantis US Small Cap Value ETF) is US small-cap value with profitability screen. Managed by Avantis, the fund carries $26.2B in assets under management, an expense ratio of 0.25%, a dividend yield of 1.29%. Its largest holding is Viasat Inc (VSAT), which represents 1.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.